​

Funding Round

Series A - Sitryx Therapeutics

Series A - Sitryx Therapeutics

Investment Firm

Overview

Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.

Announced Date

Sep 27, 2023

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Oxford Science Enterprises

Oxford Science Enterprises

Oxford Science Enterprises is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorGSK
Participant InvestorOxford Science Enterprises
Participant InvestorSofinnova Partners
Participant InvestorEli Lilly
Participant InvestorSV Health Investors

Round Details and Background

Sitryx Therapeutics raised $39000000 on 2023-09-27 in Series A

Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 08, 2018
Series A - Sitryx Therapeutics
4-30.0M
Apr 03, 2020
Corporate Round - Sitryx Therapeutics
1-10.0M
Sep 27, 2023
Series A - Sitryx Therapeutics
6-39.0M

Recent Activity

There is no recent news or activity for this profile.